THY1 and liver cancer: Furthermore, knockdown of Gli1 and Gli3 expression in CD90+ 97L liver cancer cells followed by IL6 treatment can partly reversed the inhibition of cell proliferation, sphere formation capacity and migration capacity caused by Gli1 and Gli3 knockdown (Figure 7B‐D).